Karen Possemato - Seer Chief Officer

SEER Stock  USD 2.48  0.10  4.20%   

Insider

Karen Possemato is Chief Officer of Seer Inc
Address 3800 Bridge Parkway, Redwood City, CA, United States, 94065
Phone650 453 0000
Webhttps://seer.bio

Seer Management Efficiency

The company has return on total asset (ROA) of (0.1492) % which means that it has lost $0.1492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2203) %, meaning that it created substantial loss on money invested by shareholders. Seer's management efficiency ratios could be used to measure how well Seer manages its routine affairs as well as how well it operates its assets and liabilities. As of 11/27/2024, Return On Tangible Assets is likely to drop to -0.21. In addition to that, Return On Capital Employed is likely to drop to -0.26. At this time, Seer's Fixed Asset Turnover is relatively stable compared to the past year. As of 11/27/2024, Asset Turnover is likely to grow to 0.04, while Total Assets are likely to drop slightly above 372.6 M.
Seer Inc currently holds 28.26 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. Seer Inc has a current ratio of 30.45, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Seer's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Annick DeschoolmeesterPharvaris BV
51
MD MBAShattuck Labs
65
Prof MDLyell Immunopharma
N/A
Vijay SabesanKymera Therapeutics
52
Melissa BrodyKymera Therapeutics
N/A
Gary LeeLyell Immunopharma
47
Kenneth CundyAnebulo Pharmaceuticals
65
Sonia DPHILPepGen
38
Ralph BrandenbergerNkarta Inc
55
Peter RhodeHCW Biologics
66
Sanjay ChandaAN2 Therapeutics
59
MS MBAGeneration Bio Co
46
Andreas EMBAMolecular Partners AG
58
Crystal MDLyell Immunopharma
63
Maryann CiminoPharvaris BV
N/A
Ben StrainFoghorn Therapeutics
N/A
Michael McKennaQuantumSi
62
MPH MDFoghorn Therapeutics
51
Kelly SchickC4 Therapeutics
44
Charles NewtonLyell Immunopharma
53
Jennifer CormierPepGen
N/A
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Seer Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 118 people. Seer Inc (SEER) is traded on NASDAQ Exchange in USA. It is located in 3800 Bridge Parkway, Redwood City, CA, United States, 94065 and employs 147 people. Seer is listed under Life Sciences Tools & Services category by Fama And French industry classification.

Management Performance

Seer Inc Leadership Team

Elected by the shareholders, the Seer's board of directors comprises two types of representatives: Seer inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seer. The board's role is to monitor Seer's management team and ensure that shareholders' interests are well served. Seer's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seer's outside directors are responsible for providing unbiased perspectives on the board's policies.
Marissa Dixon, Chief Officer
Asim Siddiqui, Senior Development
Martin Goldberg, Senior Development
Kenny Ross, Chief Officer
JD Esq, Chief Secretary
Joe Laws, Chief CoFounder
David Horn, President,Treasurer CFO
Serafim Batzoglou, Chief Officer
Scott Thomas, Chief Officer
Karen Possemato, Chief Officer
Christopher Mason, Member Board

Seer Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Seer a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Seer

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Seer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seer will appreciate offsetting losses from the drop in the long position's value.

Moving against Seer Stock

  0.89VALN Valneva SE ADRPairCorr
  0.8ERNA Eterna TherapeuticsPairCorr
  0.77ME 23Andme HoldingPairCorr
  0.74HLN Haleon plcPairCorr
  0.59VCNX VaccinexPairCorr
The ability to find closely correlated positions to Seer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Seer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Seer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Seer Inc to buy it.
The correlation of Seer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Seer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Seer Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Seer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Seer Stock Analysis

When running Seer's price analysis, check to measure Seer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seer is operating at the current time. Most of Seer's value examination focuses on studying past and present price action to predict the probability of Seer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seer's price. Additionally, you may evaluate how the addition of Seer to your portfolios can decrease your overall portfolio volatility.